Statins may lower mortality risk in kidney cancer patients

05/8/2013 | HealthDay News

An analysis of data from more than 900 patients who underwent surgery for renal cell carcinoma showed that statin use was associated with a lower risk of cancer progression and death. Nearly four years after surgery, 10% of statin users died of kidney cancer compared with 17% of nonusers, researchers found. The findings were reported at the annual meeting of the American Urological Association.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ